EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Interferon stimulated gene 15 (ISG15) in cancer: An update

Hong-My Nguyen, Shreyas Gaikwad, Mariam Oladejo, Manas Yogendra Agrawal, Sanjay K Srivastava, Laurence M Wood

Cancer Letters · 2023

DOI: 10.1016/j.canlet.2023.216080 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2023. Verfasst von Hong-My Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, Jerry H. Hodge School of Pharmacy, Abilene, TX, 796…. Hauptthemen laut MEDLINE: Cytokines, Neoplasms, Ubiquitins. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among the plethora of defense mechanisms which a host elicits after pathogen invasion, type 1 interferons play a central role in regulating the immune system's response. They induce several interferon-stimulated genes (ISGs) which play a diverse role once activated. Over the past few decades, there have been several studies exploring the role of ISGs in cancer and ISG15 is among the most studied for its pro and anti-tumorigenic role. In this review, we aim to provide an update on the recent observations and findings related to ISG15 in cancer. We provide a brief overview about the initial observations and important historical findings which helped scientists understand structure and function of ISG15. We aim to provide an overview of ISG15 in cancer with an emphasis on studies which delve into the molecular mechanism of ISG15 in modulating the tumor microenvironment. Further, the dysregulation of ISG15 in cancer and the molecular mechanisms associated with its pro and anti-tumor roles are discussed in respective cancer types. Finally, we discuss multiple therapeutic applications of ISG15 in current cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesNeoplasmsUbiquitinsHumansInterferon Type ITumor Microenvironment

Stichwörter der Autor:innen

CancerInterferon-stimulated gene 15Type I interferonUbiquitin-like protein

Substanzen

CytokinesInterferon Type IISG15 protein, humanUbiquitins

Autor:innen und Institutionen

  • Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, Jerry H. Hodge School of Pharmacy, Abilene, TX, 79601, USA; Center for Tumor Immunology and Targeted Cancer Therapy, Texa…

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Nguyen, H. M., Gaikwad, S., Oladejo, M., Agrawal, M. Y., Srivastava, S. K., & Wood, L. M. (2023). Interferon stimulated gene 15 (ISG15) in cancer: An update. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216080

Vancouver

Nguyen HM, Gaikwad S, Oladejo M, Agrawal MY, Srivastava SK, Wood LM. Interferon stimulated gene 15 (ISG15) in cancer: An update. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216080

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Hong-My and Gaikwad, Shreyas and Oladejo, Mariam and Agrawal, Manas Yogendra and Srivastava, Sanjay K and Wood, Laurence M},
  title = {Interferon stimulated gene 15 (ISG15) in cancer: An update},
  journal = {Cancer Letters},
  year = {2023},
  doi = {10.1016/j.canlet.2023.216080}
}
Kostenlos starten →